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OBJECTIVE: To evaluate the efficiency of long-term cataract surgery using low-cost intraocular lens implantation
in community campaigns.
METHODS: Fifty-eight randomly selected patients were evaluated four years after phacoemulsification and
Ioflex intraocular lens implantation. Causes of low visual acuity related to the intraocular lens were evaluated,
and treatment costs were calculated.
RESULTS: The mean age of patients was 72±10.2 years. Four years after surgery, 25 eyes (43.0%) had decreased
visual acuity related to the intraocular lens: posterior capsule opacification was noted in 24 eyes (41.3%), and
intraocular lens opacification was noted in one eye (1.7%). The total cost of the post-surgical complication
treatments represented 6.3% of the initial budget of the entire surgical patient group.
CONCLUSIONS: The efficiency of cataract surgery with low-cost Ioflex intraocular lens implantation was
significantly reduced in a long-term follow-up study because postoperative complications related to intraocular
lenses emerged at higher rates than when the gold-standard treatment was used.
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’ INTRODUCTION
Phacoemulsification surgery is the most widely used tech-
nique for cataract surgery due to its good visual outcomes (1).
However, long-term postoperative complications due to dif-
ferent intraocular lens (IOL) materials and designs can affect
budgets and impair the efficiency of implementing this
procedure in public healthcare systems (2,3). Given the large
number of cataract surgeries being conducted, even small
differences in costs per surgery add up to larger amounts in
total cost to the healthcare system (4).
Ioflex (Mediphacos, Belo Horizonte, MG, Brazil) is a low-
cost hydrophilic acrylic IOL commonly used in community
programs for cataract surgery for underprivileged people (2).
This IOL has been marketed for more than 15 years and has
been approved by the national health agencies in several
countries in Europe, Asia, and Latin America. An efficient
IOL should produce good results with low cost. Reports
indicate post-surgical complications related to the Ioflex
IOL (2,5) and suggest that health managers must base their
actions on clinical evidence of its efficiency (6). Thus, for the
first time, this study evaluates the long-term efficiency of
cataract surgery using the Ioflex IOL.
’ MATERIALS AND METHODS
A sample of 102 subjects was randomly selected from a
population of 192 patients who underwent cataract surgery
and Ioflex IOL implantation within the past four years
without intraoperative complications as part of a community
campaign for underprivileged people in Pernambuco, Brazil.
The follow-up time ranged from 42 to 48 months post-
operatively. The mean follow-up time was 45.6 months.
A total of 31 patients could not be located due to either
communication difficulties related to geographical distance
or patient death. Of the 71 patients located, 13 (18.3%) were
not present for examination. Thus, 58 patients were available
for examination. To avoid bias, only the right eye was
included in the study for patients who underwent cataract
surgery in both eyes.
The same surgeon performed all surgical procedures.
In each case, a 2.8-mm incision was made under peribulbar
anesthesia using a balanced salt solution (BSSs, Alcon Labs,
Fort Worth, TX, USA) and 2% methylcellulose viscoelastic
(Ophthalmus, São Paulo, Brazil). Continuous curvilinear
capsulorhexis approximately 1 mm smaller than the optical
part of the IOL and cortical clean-up procedures were used
in all cases. Data were collected from the medical records andDOI: 10.6061/clinics/2017(09)04
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included information about the patient’s ocular health, pre-
surgical corrected visual acuity (VA), and postoperative
corrected VA after one month. Examination of the corrected
VA, a biomicroscopy slit lamp examination, and fundoscopy
were performed at the evaluation four years after the surgery.
Posterior capsule opacification (PCO) was diagnosed during
the slit lamp examination, and the decision regarding laser
capsulotomy was based on VA deterioration. Patients with
worsened VA (one line or more on Snellen card notation)
compared to that measured one month after surgery, without
improvement with glasses, that was related to PCO were
referred for neodymium:yttrium-aluminum-garnet (Nd:YAG)
laser treatment.
Surgical and post-surgical procedure costs were based on
Brazilian Health System guidelines. All values were con-
verted to US dollars (USD) at a rate of one dollar to R$ 3.1
(Brazilian currency).
The postoperative complications of the IOL were com-
pared with those of a gold-standard hydrophobic IOL
(AcrySof SN60 one-piece, Alcon, Fort Worth, TX, USA) based
on a study by Cullin et al. (7), who evaluated PCO rates and
related costs for three different IOLs in a retrospective study
of 1,527 patients with a mean follow-up time of 41.5 months,
ranging from 19 to 76 months. The mean follow-up time of
patients with the hydrophobic AcrySof IOL was 41.4 months.
The study included Nd:YAG capsulotomy patients with
development of postoperative PCO and clinical signs of
secondary visual impairment, such as reduced VA or glare.
Both our study and that by Cullin et al. (7) detected PCO
at an outpatient visit. The criterion that we used for PCO
was visual loss after primary cataract surgery as subjective
data to suggest the necessity of Nd:YAG laser capsulotomy.
In addition, none of the studies described the use of Trypan
blue during the surgeries.
Ethics
This study was approved by the Ethics Committee of the
Altino Ventura Foundation (054/2011) in accordance with
the Helsinki Declaration.
’ RESULTS
The mean age of the patients who received an Ioflex IOL
was 72.0±10.2 years. The mean preoperative corrected VA
was 0.79±0.41 logMAR (20/125 in Snellen card notation).
One month after surgery, the mean corrected VA improved
to 0.25±0.20 logMAR (20/35 in Snellen card notation),
except for one patient who experienced a posterior seg-
ment problem. Four years after surgery, 39 (67.0%) of the
58 evaluated eyes had detectable PCO upon biomicroscopy
evaluation, and 24 eyes (41.3%) had decreased VA due to
PCO. Patients with slight PCO underwent a new refrac-
tive examination for updated glasses and exhibited a mean
corrected VA of 0.13±0.03 logMAR (20/26 in Snellen card
notation), whereas the mean corrected VA of the 24 patients
with decreased VA due to PCO was 0.53±0.21 logMAR
(20/67 in Snellen card notation). These patients were referred
for Nd:YAG laser capsulotomy and consequently demon-
strated a corrected VA that had recovered to 0.05±0.06 logMAR
(20/22 in Snellen card notation). One patient (1.7%) exhibited
decreased VA from 0.09 logMAR at one month after surgery
to 0.6 logMAR 4 years after surgery (20/25 to 20/80 in
Snellen card notation). This result was due to IOL opacifica-
tion, and the patient was referred for IOL exchange, resulting
in a final corrected VA recovery to 0 logMAR (20/20 in
Snellen card notation). Two additional patients with PCO
were diagnosed with glaucoma and posterior segment disease.
The cost of each Ioflex IOL was USD $50.00, and the cost
of each gold-standard hydrophobic IOL was USD $99.59.
The costs of the cataract surgery, Nd:YAG laser capsulotomy
procedures, and IOL exchange are listed in Table 1. The addi-
tional cost to maintain a good visual outcome 4 years after
surgery was USD $9.03 per patient with Ioflex IOL implanta-
tion, whereas the estimated cost of a gold-standard IOL
implant would have been USD $1.07 per patient. Thus, the
low-cost IOL is USD $7.96 greater than the gold standard
IOL in the initial surgery budget (5.5%). The cost of the post-
surgical procedures using the Ioflex IOL represents 6.3%
(USD $524.00) of the initial budget of the entire surgical
patient group.
’ DISCUSSION
The results revealed high rates of late postoperative com-
plications related to the IOL, with significant PCO in 41.3%
of patients and IOL opacification in 1.7% of patients who
underwent Ioflex hydrophilic acrylic IOL implantation. For
the gold-standard hydrophobic acrylic IOL, 7.4% of patients
had PCO, and no IOL opacification was reported (7). Hydro-
philic acrylic lenses are associated with higher rates of PCO
than hydrophobic IOLs.
Few papers report PCO evaluation more than four years
after surgery. Ronbeck et al. (8) reported that hydrophobic
acrylic IOLs delayed PCO development, with a median time
of survival without Nd:YAG capsulotomy of 108 months.
PCO rates were reported for approximately 50% of the patients
approximately 10 years after surgery. We found similar rates
approximately 4 years after surgery. Chang et al. (9) reported a
rate of 10% for Nd:YAG laser capsulotomy for a one-piece
hydrophobic IOL and 22% for a 3-piece hydrophobic IOL 5 to
7 years after surgery. These results demonstrate that hydro-
phobic acrylic IOLs may delay the need for laser capsulotomy
for several years in eyes submitted to cataract surgery and
exhibit lower occurrence rates than hydrophilic acrylic PCO
rates. Given that the life expectancy of people worldwide is
increasing, it is important to delay the occurrence of post-
operative complications as much as possible.
Vasavada et al. (10) reported Nd:YAG laser capsulotomy
cases in 12.9% and 16% of the hydrophilic IOLs evaluated
and none in the hydrophobic group 3 years after surgery.
Kugelberg et al. (11) reported capsulotomy in 42% of a
hydrophilic IOL group compared to 10% in a hydrophobic
group at 2 years after surgery. Gauthier et al. (12) reported an
increasing number of Nd:YAG laser treatments over time,
with 8.8% in the hydrophobic IOL group and 37.2% in
the hydrophilic lens group with a follow-up of 24 months.
The results from these studies are consistent with our results.
Table 1 - Surgical and post-surgical procedures expenses refund








Cataract surgery 142.90 58 8,288.20
Nd:YAG laser 14.51 24 348.24
IOL exchange 175.76 1 175.76
544
Long-term efficiency of cataract surgery
Jorge PA et al.
CLINICS 2017;72(9):543-546
This information could provide a basis for discussions about
the long-term economic consequences of choosing an IOL
with a design that affects the risk of PCO development.
It is not yet known whether the occurrence of PCO in
hydrophobic IOLs is only 50% or continues to increase after
12 years post-surgery (8). Similarly, it is not known whether
hydrophilic IOLs will continue to exhibit greater PCO rates
than hydrophobic IOLs. More studies are needed to better
explain PCO evolution. The results of our study allows us to
estimate the future trends to at least better prepare managers
and public health programs.
We have previously reported the occurrence of Ioflex IOL
opacification, which exhibited and incidence rate of 7% (5).
The current finding of a 1.7% IOL opacification rate was due
to the selection criterion, which included only one eye of
each patient. This criterion was not used in previous research.
Although opacification is not a common complication, it is the
main cause of hydrophilic acrylic IOL extraction. The causes
of this complication are not completely understood, but the
literature indicates that it is caused by calcification due to
calcium and/or phosphate in the IOL (13).
Due to technological advances, the IOL design has been
modified from a round edge to include a square edge, which
has resulted in a reduction in the incidence of PCO (12).
However, studies suggest that square-edged IOLs should
completely encompass the 360 degrees around the IOL optic
to provide an effective barrier (14). Furthermore, another
study demonstrated differences between brands of square-
edged lenses, suggesting that variations in their edge profiles
may account for clinical differences in postoperative PCO
rates (15). Acrylic IOLs also appear to lose their PCO pre-
ventive effect despite their sharp optic edges (8,16).
Our study suggests that the initial savings of USD $49.59
per patient with the use of the hydrophilic IOL compared
to the hydrophobic IOL is reduced when considering the
additional cost of treatments for avoidable postopera-
tive complications. We estimate that the Ioflex IOL loses its
efficiency, as it costs USD $7.96 more than the gold standard
IOL in the initial surgical budget (5.5%). However, even with
the additional cost of postoperative treatments, the total cost
was still lower when using the low-cost IOL.
Community cataract programs are performed world-
wide in developing countries (2,17). Reviews of blindness
in regions such as Latin America, Nigeria, Cameroon, and
India reported a need to improve the implementation of
social action programs to prevent blindness and improve
cataract surgery outcomes (18-23). In a long-term post-
operative follow-up study, De Senne et al. (24) demonstrated
that 75.6% (Project A) and 64.7% (Project B) of patients
experienced low VA due to postoperative complications in a
community cataract program in Brazil (mainly PCO and
refractive errors). This finding indicates that long-term post-
surgical complications can be as harmful as failing to have
the cataract extracted.
Data from this study highlight the need for community
cataract programs to provide easy access to specialized
services over a long follow-up period to ensure the initial
efficiency of the cataract treatment. This notion is particularly
important when hydrophilic acrylic IOLs are used, especially
the Ioflex IOL, which is widely used in community campaigns
in Brazil given its low cost. Long-term postoperative com-
plications pose a risk for the efficiency of cataract treatment.
This risk could be partially avoided by using better IOLs
with proven clinical results given that the majority of
post-surgical complications with poor visual outcomes are
related to low-cost IOLs (2,25).
This study revealed that use of the Ioflex acrylic hydro-
philic IOL may cause the public health system to spend
almost 6.3% more than the initial budget on post-surgical
treatments. Therefore, the results of this paper should make
managers aware that they should schedule an outpatient
visit at least 4 years after surgery if the low-cost hydro-
philic IOL is used and reserve a budget for Nd:YAG laser
capsulotomy. In contrast, for hydrophobic IOLs, the visit
could be scheduled 10 years after surgery.
The current study had some important limitations. The
comparison was performed with another study, specifically a
retrospective study with a different population and different
surgeons. The follow-up time of PCO evaluation was similar
but was not identical. None of the studies determined
a criterion for software for image analysis to evaluate the
severity of PCO. However, we believe that despite this
limitation, the results were interesting and worth reporting.
In conclusion, the material and design of the Ioflex IOL
afford it short-term effectiveness, but reduced efficiency for
long-term cataract surgery is noted upon follow-up. After
surgery, an increased number of patients underwent laser
capsulotomy in a shorter period of time than with the high-
cost IOLs. We have highlighted the social impact of a cost-
effective IOL, particularly for public healthcare policies in
developing countries.
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